DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Lipshultz SE, Scully RE, Lipsitz SR, Sallan SE, Silverman LB, Miller TL. et al.
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: Long-term follow-up of a prospective, randomised, multicentre trial.
Lancet Oncol 2010;
11: 950-61
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.